Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study

Lancet

Volumn 354, Issue 9172, 1999, Pages 20-25

  Nobbenhuis, Mariëlle A E ^a   Walboomers, Jan M M ^a   Helmerhorst, Theo J M ^a   Rozendaal, Lawrence ^a   Remmink, Ans J ^a   Risse, Elle K J ^a   Van Der Linden, Hans C ^a   Voorhorst, Feja J ^a   Kenemans, Peter ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CYTOLOGY; DISEASE COURSE; DYSKARYOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0033519946     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)12490-X     Document Type: Article

References (30)

1. Richart R.M., Barron B.A. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 105:1996;386-393.
2. Van der Graaf Y., Zielhuis G.A., Peer P.G.M., Vooijs P.G. The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol. 41:1988;21-26.
3. Koss L.G. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA. 261:1989;737-743.
4. IARC monograph on the evaluation of carcinogenic risks to humans, vol 64: human papillomaviruses. Lyon, France: International Agency for Research on Cancer, 1995.
5. Bosch F.X., Manos M.M., Muñoz N.et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 87:1995;796-802.
6. Schiffman M.H., Bauer H.M., Hoover R.Net al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 85:1993;958-964.
7. Syrjänen K.J. Biological behaviour of cervical intraepithelial neoplasia. Franco E., Monsonego J. New developments in cervical cancer screening and prevention. 1997;93-108 Blackwell Science, London.
8. Schiffman M.H., Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer. 76:1995;1888-1901.
9. Kjør S.K., van den Brule A.J.C., Bock J.E.et al. Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer. 65:1996;601-606.
10. Chichareon S., Herrero R., Muñoz Net al. Risk factors for cervical cancer in Thailand: a case control study. J Natl Cancer Inst. 90:1998;50-57.
11. Ngeangel C., Muñoz N., Bosch X.F.et al. The causes of cervical cancer in the Philippines: a case control study. J Natl Cancer Inst. 90:1998;43-49.
12. Koutsky L.A., Holmes K.K., Critchlow C.W.et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 327:1992;1272-1278.
13. Cuzick J., Szarewski A., Terry G.et al. Human papillomavirus testing in primary cervical cancer screening. Lancet. 345:1995;1533-1536.
14. Meijer C.J.L.M., Rozendaal L., van der Linden J.C., Helmerhorst Th.J.M., Voorhorst F.J., Walboomers J.M.M. Human papillomavirus testing for primary cervical cancer screening. Franco E., Monsonego J. New developments in cervical cancer screening and prevention. 1997;338-347 Blackwell Science, London.
15. Meijer C.J.L.M., Helmerhorst Th.J.M., Rozendaal L., van der Linden J.C., Voorhorst F.J., Walboomers J.M.M. Human papillomavirus typing or testing in gynaecopathology: has the time come? Histopathology. 33:1998;83-86.
16. Walboomers J.M.M., Jacobs M.V., van Oostveen J.W., van den Brule A.J.C., Snijders P.J.F., Meijer C.J.L.M. Detection of genital human papillomavirus infections and possible clinical implications. Gross G., Von Krogh G. Human papillomavirus infections in dermatovenerology. 1997;341-364 CRC Press, Boca Raton, New York.
17. Remmink A.J., Walboomers J.M.M., Helmerhorst Th.J.M.et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 61:1995;306-311.
18. Vooijs G.P. De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri. Ned Tijdschr Geneeskd. 131:1987;1662-1663.
19. Hopman E.H., Kenemans P., Helmerhorst Th.J.M. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Surv. 53:1998;97-105.
20. Hopman E.H., Voorhorst F.J., Kenemans P., Meijer C.J.L.M., Helmerhorst Th, J M. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol. 58:1995;206-209.
21. Helmerhorst Th.J.M., Dijkhuizen G.H., Calame J.J., Kwikkel H.J., Stolk J.G. The accuracy of colposcopically directed biopsy in diagnosis of CIN. Eur J Obstet Gynecol Reprod Biol. 24:1987;221-229.
22. Anderson M.C. Premalignant and malignant squamous lesions of the cervix. Fox H., Wells M. Haines and Taylor: obstetrical and gynaecological pathology, 4th edn. 1995;292-297 Churchill Livingstone, New York.
23. Wright T.C., Kurman R.J., Ferenczy A. Precancerous lesions of the cervix. Kurman R.J. Blaustein's pathology of the female genital tract, 4th edn. 1995;248-257 Springer Verlag, New York.
24. De Roda Husman A.M., Walboomers J.M.M., van den Brule A.J.C., Meijer C.J.L.M., Snijders P.J.F. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 76:1995;1057-1062.
25. Jacobs M.V., van den Brule A.J.C., Snijders P.J.F., Meijer C.L.J.M., Helmerhorst Th.J.M., Walboomers J.M.M. A general primer GP5+/6+ mediated PCR-EIA for rapid detection of high- and low-risk HPV DNA in cervical scrapes. J Clin Microbiol. 35:1997;791-795.
26. Ho G.Y.F., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 338:1998;423-428.
27. Bauer H.M., Hildesheim A., Schiffman M.H.et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis. 20:1993;274-277.
28. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus, a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 (in press).
29. Ho G.Y.F., Burk R.D., Klein S.et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365-1371.
30. Kataja V., Syrjänen S., Mäntyjärvi R., Yliskoski M., Saarikoski S., Syrjänen K. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis. 19:1992;154-160.